This page brings together all the PrescQIPP diabetes resources and showcase good practice examples of projects focusing on medicines optimisation in diabetes. Each set of resources contains tools that can be adapted for local use before implementation.
Implementing QIPP Projects in Diabetes SWOT Analysis
The Implementing the diabetes QIPP project planning tool will support medicines management teams in identifying key projects and stakeholders and support teams through the process of implementing the diabetes projects. A swot analysis is included as well as other project planning tools which are all adaptable to meet local need.
Diabetes Webkit Webinar
In this webinar, Sajida Khatri, PrescQIPP primary care lead showcased the newly developed Diabetes webkit and also discussed the updated bulletins, resource materials and current evidence base. Subscibers can now view this webinar below:
Optimising Medicines for Adults with Type 2 Diabetes E-learning Course
The e-learning course has been commissioned by the Eastern Academic Health Science Network and developed by PrescQIPP. The package is designed to support clinicians to implement NICE guidance on managing Type 2 diabetes in adults, with a particular focus on optimising the use of medicines to achieve the best possible outcomes for patients.
It is has been designed for practice nurses, practice pharmacists, GPs and any clinician with an interest in the management of patients with Type 2 diabetes and can be freely accessed by all registered NHS users.
The package consists of seven modules covering all aspects of NICE guidance on the management of Type 2 diabetes in adults, and three case studies to test understanding and to demonstrate application of the guidance to clinical practice.
Each module has information and links to other resources which support the delivery of high quality diabetes care, and the rational and effective use of medicines.
The training slideset for diabetes is a resource that can be used by medicines management teams locally (in collaboration with diabetes specialist teams) to deliver training in the management of type 2 diabetes. The slidesets will be presented in modules which can be broken down into shorter training sessions and include:
- Medicines optimisation in diabetes
- Patient education and lifestyle interventions
- Managing blood pressure and cardiovascular risk
- Blood glucose management and self-monitoring of blood glucose
- Blood glucose lowering treatments
- The impact of diabetes and aims of treatment
- Managing complications
Subscribers can access the slidesets here:
Diabetes Snapshot Reports and Visual Analytics (login to view)
If you are a subscriber you can log in to view the Visual Analytics version of the Diabetes Snapshot.
Oral Hypoglycaemics and Other Antidiabetic Agents
B157: Management of Type 2 Diabetes
The management of type 2 diabetes bulletin and briefing discuss the evidence base for the currently available antidiabetic drugs and their place in therapy for type 2 diabetes in line with NICE guidance.
B157: Summary Diabetes Treatment Pathway
The algorithm and table comparing treatments provide an at a glance guide to treatment options in diabetes.
B157: Audit and Implementation Tools
The supporting audit and implementation tools, which include patient information and letters, are available here. The audit is available as an overarching big audit or smaller audits for individual drug classes.
The Management of Type 2 Diabetes Data Pack
The bulletin focuses on alogliptin which is the fifth dipeptidylpeptidase-4 (DPP-4) inhibitor licensed in the UK. The document includes recommendations to ensure prescribing is in line with NICE guidance, considers clinical effectiveness in relation to dual therapy and triple therapy, combination products and also safety considerations. The resource includes a GP decision aid, data collection form, patient invite for diabetes review, along with a data pack and implementation version for subscribers.
Alogliptin Data Pack
B44: Gliclazide MR DROP-List
This bulletin focuses on gliclazide modified release and provides the rationale for new patients to be commenced on gliclazide standard release, and for current patients to be considered for a switch to either metformin or gliclazide (or both depending on where the patient is on the treatment pathway). It also reviews the use of metformin modified release and offers advice on switching appropriate patients to standard release metformin.
Innovation Award Entry 2013: Is the Use of Newer Diabetic Medicines in Primary Care in Line With NICE Guidance - Herefordshire CCG
B46: Blood Glucose Testing Strips
The bulletin and accompanying documents focus on appropriate prescribing of blood glucose testing strips for people with type 2 diabetes and also improving prescribing efficiencies in this area. It includes recent prescribing figures and potential savings from switching patients on to cost-effective blood glucose meters and testing strips. An implementation guide for blood glucose meter selection is also available.
Innovation Award Winner 2013: Blood Glucose Meter Switch Program - Bedfordshire CCG
This short bulletin advises on cost effective choices of lancets.
B102: Insulin Analogues
The insulin analogues bulletin reviews the current place in therapy for the long acting and biphasic insulin analogues and provides guidance on appropriate prescribing in line with NICE guidance.
Insulin Data Pack
B103: Insulin Needles
This bulletin updates the needle section from bulletin 16, which has now been developed as a stand alone bulletin. It looks at cost effective choices of needles and also advises on the appropriate use of safer sharps.